COVID-19 and Thrombosis Complication in Children

Herlina Dimiati; Nina Widasari

doi:10.3889/oamjms.2022.9837

Authors

Herlina Dimiati Pediatric Cardiology Division, Medical Faculty, Syiah Kuala University, Kota Banda Aceh, Aceh, Indonesia
Nina Widasari Pediatric Cardiology Division, Medical Faculty, Syiah Kuala University, Kota Banda Aceh, Aceh, Indonesia

DOI:

https://doi.org/10.3889/oamjms.2022.9837

Keywords:

COVID-19, Thrombosis, Children

Abstract

Since it was discovered in Wuhan in December 2019, most studies on COVID-19 have been centered on symptomatic adults. An expanded pro-inflammatory cytokine reaction, abnormal clot formation, overactive platelets, and hypercoagulable state are among the well-known clinical characteristics of endothelial dysfunction that may arise in patients with COVID-19. These conditions can lead to venous thromboembolism, arterial thrombosis, and pulmonary embolism. To date, the predominance of thromboembolic complications in children infected with severe acute respiratory syndrome coronavirus 2 has not been fully documented, and there is no explicit recommendation for the prevention of thrombosis in children.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020;579(7798):265-9. https://doi.org/10.1038/s41586-020-2008-3 PMid:32296181 DOI: https://doi.org/10.1038/s41586-020-2008-3

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. https://doi.org/10.1016/S0140-6736(20)30183-5 PMid:31986264 DOI: https://doi.org/10.1016/S0140-6736(20)30183-5

Maier CL, Truong AD, Auld SC, Polly DM, Tanksley CL, Duncan A. COVID-19-associated hyperviscosity: A link between inflammation and thrombophilia? Lancet. 2020;395(10239):1758-59. https://doi.org/10.1016/S0140-6736(20)31209-5 PMid:32464112 DOI: https://doi.org/10.1016/S0140-6736(20)31209-5

Guillaume H, Kerneis M, Zeitouni M, Cohen-Aubart F, Chommeloux J, Bréchot N, et al. Coronavirus disease 2019 acute myocarditis and multisystem inflammatory syndrome in adult intensive and cardiac care units. Chest. 2021;159(2):657-62. https://doi.org/10.1016/j.chest.2020.08.2099 PMid:32910974 DOI: https://doi.org/10.1016/j.chest.2020.08.2099

Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H, et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. 2020;130(5):2620-9. https://doi.org/10.1172/JCI137244 PMid:32217835 DOI: https://doi.org/10.1172/JCI137244

Colafrancesco S, Scrivo R, Cristiana Barbati C, Conti F, Priori R. Targeting the immune system for pulmonary inflammation and cardiovascular complications in COVID-19 patients. Front Immunol. 2020;11:1439. https://doi.org/10.3389/fimmu.2020.01439 PMid:32655577 DOI: https://doi.org/10.3389/fimmu.2020.01439

Zaffanelo M, Piacentini G, Nosetti L, Ganzarolli S, Franchini M. Thrombotic risk in children with COVID-19 infection: A systematic review of the literature. Thromb Res. 2021;205:92-8. https://doi.org/10.1016/j.thromres.2021.07.011 PMid:34293539 DOI: https://doi.org/10.1016/j.thromres.2021.07.011

He J, Guo Y, Mao R, Zhang J. Proportion of asymptomatic coronavirus disease 2019: A systematic review and metaanalysis. J Med Virol. 2021;93(2):820-30. https://doi.org/10.1002/jmv.26326 PMid:32691881 DOI: https://doi.org/10.1002/jmv.26326

Ma Y, Xu QN, Wang FL, Ma XM, Wang XY, Zhang XG, et al. Characteristics of asymptomatic patients with SARS-CoV-2 infection in Jinan, China. Microbes Infect. 2020;22(4–5):212-17. https://doi.org/10.1016/j.micinf.2020.04.011 PMid:32387682 DOI: https://doi.org/10.1016/j.micinf.2020.04.011

Lu X, Zhang L, Du H, Zhang J, Li YY, Qu J, et al. SARS-CoV-2 infection in children. N Engl J Med. 2020;382(17):1663-5. https://doi.org/10.1056/NEJMc2005073 PMid:32187458 DOI: https://doi.org/10.1056/NEJMc2005073

Qiu H, Wu J, Hong L, Luo Y, Song Q, Chen D. Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: An observational cohort study. Lancet Infect Dis. 2020;20(6):689-96. https://doi.org/10.1016/S1473-3099(20)30198-5 PMid:32220650 DOI: https://doi.org/10.1016/S1473-3099(20)30198-5

Su L, Ma X, Yu H, Zhang Z, Bian P, Han Y, et al. The different clinical characteristics of corona virus disease cases between children and their families in China-the character of children with COVID-19. Emerg Microbes Infect. 2020;9(1):707-13. https://doi.org/10.1080/22221751.2020.1744483 PMid:32208917 DOI: https://doi.org/10.1080/22221751.2020.1744483

Wang D, Ju XL, Xie F, Lu Y, Li FY, Huang HH, et al. Clinical analysis of 31 cases of 2019 novel coronavirus infection in children from six provinces (autonomous region) of Northern China. Zhonghua Er Ke Za Zhi. 2020;58(4):269-74. https://doi.org/10.3760/cma.j.cn112140-20200225-00138 PMid:32118389

Chen F, Liu ZS, Zhang FR, Xiong RH, Chen Y, Cheng XF, et al. First case of severe childhood novel coronavirus pneumonia in China. Zhonghua Er Ke Za Zhi. 2020;58(3):179-82. https://doi.org/10.3760/cma.j.issn.0578-1310.2020.03.003 PMid:32135586

Riphagen S, Gomez X, Gonzalez-Martinez C, Wilkinson N, Theocharis P. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet. 2020;395(10237):1607-8. https://doi.org/10.1016/S0140-6736(20)31094-1 PMid:32386565 DOI: https://doi.org/10.1016/S0140-6736(20)31094-1

Verdoni L, Mazza A, Gervasoni A, Martelli L, Ruggeri M, Ciuffreda M, et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: An observational cohort study. Lancet. 2020;395(10239):1771-8. https://doi.org/10.1016/S0140-6736(20)31103-X PMid:32410760 DOI: https://doi.org/10.1016/S0140-6736(20)31103-X

Kim L, Whitaker M, O’Halloran A, Kambhampati A, Chai SJ, Reingold A, et al. Hospitalization rates and characteristics of children aged <18 years hospitalized with laboratory-confirmed COVID-19-COVID-NET, 14 States, March 1-July 25, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(32):1081-8. https://doi.org/10.15585/mmwr.mm6932e3 PMid:32790664 DOI: https://doi.org/10.15585/mmwr.mm6932e3

Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of novel coronavirusinfected pneumonia. N Engl J Med. 2020;382(13):1199-207. https://doi.org/10.1056/NEJMoa2001316 PMid:31995857 DOI: https://doi.org/10.1056/NEJMoa2001316

Fang F, Luo XP. Facing the pandemic of 2019 novel coronavirus infections: The pediatric perspectives. Zhonghua Er Ke Za Zhi. 2020;58:E001. https://doi.org/10.3760/cma.j.issn.0578-1310.2020.0001 PMid:32023678

McFadyen JD, Stevens H, Peter K. The emerging threat of (Micro) thrombosis in COVID-19 and its therapeutic implications. Circ Res. 2020;127(4):571-87. https://doi.org/10.1161/CIRCRESAHA.120.317447 PMid:32586214 DOI: https://doi.org/10.1161/CIRCRESAHA.120.317447

Panigada M, Bottino N, Tagliabue P, Grasselli G, Novembrino C, Chantarangkul V, et al. Hypercoagulability of COVID-19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis. J Thromb Haemost. 2020;18(7):1738-42. https://doi.org/10.1111/jth.14850 PMid:32302438 DOI: https://doi.org/10.1111/jth.14850

Bigdelian H, Sedighi M, Sabri MR, Dehghan B, Mahdavi C, Ahmadi A, et al. Case report: Acute intracardiac thrombosis in children with coronavirus disease 2019 (COVID-19). Front Pediatr. 2021;9:656720. https://doi.org/10.3389/fped.2021.656720 PMid:34249807 DOI: https://doi.org/10.3389/fped.2021.656720

Chima M, Williams D, Thomas NJ, Krawiec C. COVID-19-associated pulmonary embolism in pediatric patients.

Hosp Pediatr. 2021;11(6):e90-4. https://doi.org/10.1542/hpeds.2021-005866 PMid:33785517 DOI: https://doi.org/10.1542/hpeds.2021-005866

Carpenter SL, Richardson T, Hall M. Increasing rate of pulmonary embolism diagnosed in hospitalized children in the United States from 2001 to 2014. Blood Adv. 2018;2(12):1403-8. https://doi.org/10.1182/bloodadvances.2017013292 PMid:29907635 DOI: https://doi.org/10.1182/bloodadvances.2017013292

Navanandan N, Stein J, Mistry RD. Pulmonary embolism in children. Pediatr Emerg Care. 2019;35(2):143-51. https://doi.org/10.1097/PEC.0000000000001730 PMid:30702542 DOI: https://doi.org/10.1097/PEC.0000000000001730

Anderson MR, Geleris J, Anderson DR, Zucker J, Nobel YR, Freedberg D, et al. Body mass index and risk for intubation or death in SARS-CoV-2 infection. Ann Intern Med. 2020;173(10):782-90. https://doi.org/10.7326/M20-3214 PMid:32726151 DOI: https://doi.org/10.7326/M20-3214

Poyiadji N, Cormier P, Patel PY, Hadied MO, Bhargava P, Khanna K, et al. Acute pulmonary embolism and COVID-19. Radiology. 2020;297(3):E335-8. https://doi.org/10.1148/radiol.2020201955 PMid:32407256 DOI: https://doi.org/10.1148/radiol.2020201955

Delabranche X, Helms J, Meziani F. Immunohaemostasis: A new view on haemostasis during sepsis. Ann Intensive Care. 2017;7(1):117. https://doi.org/10.1186/s13613-017-0339-5 PMid:29197958 DOI: https://doi.org/10.1186/s13613-017-0339-5

Engelmann B, Massberg S. Thrombosis as an intravascular effector of innate immunity. Nat Rev Immunol. 2013;13(1):34-45. https://doi.org/10.1038/nri3345 PMid:23222502 DOI: https://doi.org/10.1038/nri3345

Jackson SP, Darbousset R, Schoenwaelder SM. Thromboinflammation: Challenges of therapeutically targeting coagulation and other host defense mechanisms. Blood. 2019;133(9):906-18. https://doi.org/10.1182/blood-2018-11-882993 PMid:30642917 DOI: https://doi.org/10.1182/blood-2018-11-882993

Smith SA, Mutch NJ, Baskar D, Rohloff P, Docampo R, Morrissey JH. Polyphosphate modulates blood coagulation and fibrinolysis. Proc Natl Acad Sci U S A. 2006;103(4):903-8. https://doi.org/10.1073/pnas.0507195103 PMid:16410357 DOI: https://doi.org/10.1073/pnas.0507195103

Subramaniam S, Jurk K, Hobohm L, Jäckel S, Saffarzadeh M, Schwierczek K, et al. Distinct contributions of complement factors to platelet activation and fibrin formation in venous thrombus development. Blood. 2017;129(16):2291-302. https://doi.org/10.1182/blood-2016-11-749879 PMid:28223279 DOI: https://doi.org/10.1182/blood-2016-11-749879

Iba T, Levy JH. Inflammation and thrombosis: Roles of neutrophils, platelets and endothelial cells and their interactions in thrombus formation during sepsis. J Thromb Haemost. 2018;16(2):231-41. https://doi.org/10.1111/jth.13911 PMid:29193703 DOI: https://doi.org/10.1111/jth.13911

Noubouossie DF, Reeves BN, Strahl BD, Key NS. Neutrophils: Back in the thrombosis spotlight. Blood. 2019;133(20):2186-97. https://doi.org/10.1182/blood-2018-10-862243 PMid:30898858 DOI: https://doi.org/10.1182/blood-2018-10-862243

Rittirsch D, Flierl MA, Ward PA. Harmful molecular mechanisms in sepsis. Nat Rev Immunol. 2008;8(10):776-87. https://doi.org/10.1038/nri2402 PMid:18802444 DOI: https://doi.org/10.1038/nri2402

Iba T, Levy JH. Derangement of the endothelial glycocalyx in sepsis. J Thromb Haemost. 2019;17(2):283-94. https://doi.org/10.1111/jth.14371 PMid:30582882 DOI: https://doi.org/10.1111/jth.14371

Saffarzadeh M, Juenemann C, Queisser MA, Lochnit G, Barreto G, Galuska SP, et al. Neutrophil extracellular traps directly induce epithelial and endothelial cell death: A predominant role of histones. PLoS One. 2012;7(2):e32366. https://doi.org/10.1371/journal.pone.0032366 PMid:22389696 DOI: https://doi.org/10.1371/journal.pone.0032366

Ferrario CM, Jessup J, Chappell MC, Averill DB, Brosnihan KB, Tallant EA, et al. Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensinconverting enzyme 2. Circulation. 2005;111(20):2605-10. https://doi.org/10.1161/CIRCULATIONAHA.104.510461 PMid:15897343 DOI: https://doi.org/10.1161/CIRCULATIONAHA.104.510461

Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395(10234):1417-8. https://doi.org/10.1016/S0140-6736(20)30937-5 PMid:32325026 DOI: https://doi.org/10.1016/S0140-6736(20)30937-5

Iba T, Levy JH, Thachil J, Wada H, Levi M, Scientific and Standardization Committee on DIC of the International Society on Thrombosis and Haemostasis. The progression from coagulopathy to disseminated intravascular coagulation in representative underlying diseases. Thromb Res. 2019;179:11-4. https://doi.org/10.1016/j.thromres.2019.04.030 PMid:31059996 DOI: https://doi.org/10.1016/j.thromres.2019.04.030

Aguilera-Alonso D, Murias S, Garde AM, Soriano-Arandes A, Pareja M, Otheo E, et al. Prevalence of thrombotic complications in children with SARS-CoV-2. BMJ. 2021;106:1129-31. http://doi.org/10.1136/archdischild-2020-321351 PMid:33931403 DOI: https://doi.org/10.1136/archdischild-2020-321351

Iba T, Levy JH, Wada H, Thachil J, Warkentin TE, Levi M, et al. Differential diagnoses for sepsis-induced disseminated intravascular coagulation: Communication from the SSC of the ISTH. J Thromb Haemost. 2019;17(2):415-9. https://doi.org/10.1111/jth.14354 PMid:30618150 DOI: https://doi.org/10.1111/jth.14354

Yu Y, Chen P. Coronavirus disease 2019 (COVID-19) in neonates and children from China: A review. Front Pediatr. 2020;8:287. https://doi.org/10.3389/fped.2020.00287 PMid:32574286 DOI: https://doi.org/10.3389/fped.2020.00287

Ortel TL, Neumann I, Ageno W, Beyth R, Clark NP, Cuker A, et al. American society of hematology 2020 guidelines for management of venous thromboembolism: Treatment of deep vein thrombosis and pulmonary embolism. Blood Adv. 2020;4(19):4693-738. https://doi.org/10.1182/bloodadvances.2020001830 PMid:33007077 DOI: https://doi.org/10.1182/bloodadvances.2020001830

Spyropoulos AC, Levy JH, Ageno W, Connors JM, Hunt BJ, Iba T, et al. Scientific and standardization committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID-19. J Thromb Haemost. 2020;18(8):1859-65. https://doi.org/10.1111/jth.14929 PMid:32459046 DOI: https://doi.org/10.1111/jth.14929

Loi M, Branchford B, Kim J, Self C, Nuss R. COVID-19 anticoagulation recommendations in children. Pediatr Blood Cancer. 2020;67(9):e28485. https://doi.org/10.1002/pbc.28485 PMid:32558124 DOI: https://doi.org/10.1002/pbc.28485

Kenchappa Y, Hegde S, Kumar P, Lalitha AV, Bukelo M. Caught off guard with COVID-19 bowel gangrene: A case report. Indian J Crit Care Med. 2020;24(12):1269-71. https://doi.org/10.5005/jp-journals-10071-23681 PMid:33446984 DOI: https://doi.org/10.5005/jp-journals-10071-23681

Essajee F, Solomons R, Goussard P, van Toorn R. Child with tuberculous meningitis and COVID-19 coinfection complicated by extensive cerebral sinus venous thrombosis. BMJ Case Rep. 2020;13(9):e238597. https://doi.org/10.1136/bcr-2020-238597 PMid:32928816 DOI: https://doi.org/10.1136/bcr-2020-238597

Hussain Z, Wangmo R, Gonbo S. Deep vein thrombosis after trivial blunt trauma at high altitude in a SARS-CoV-2 positive child: Complication of the hypercoagulable state. Indian Pediatr. 2020;57(12):1182-3. https://doi.org/10.1007/s13312-020-2077-2 PMid:33318328 DOI: https://doi.org/10.1007/s13312-020-2077-2

Lang P, Eichholz T, Bakchoul T, Streiter M, Petrasch M, Bosmüller H, et al. Defibrotide for the treatment of pediatric inflammatory multisystem syndrome temporally associated with severe acute respiratory syndrome Coronavirus 2 infection in 2 pediatric patients. J Pediatric Infect Dis Soc. 2020;9(5):622-5. https://doi.org/10.1093/jpids/piaa117 PMid:32951037 DOI: https://doi.org/10.1093/jpids/piaa117

Visveswaran GK, Morparia K, Narang S, Sturt C, Divita M, Voigt B, et al. Severe acute respiratory syndrome Coronavirus 2 infection and thrombosis: Phlegmasia cerulea dolens presenting with venous gangrene in a child. J Pediatr. 2020;226:281-4.e1. https://doi.org/10.1016/j.jpeds.2020.07.032 PMid:32673617 DOI: https://doi.org/10.1016/j.jpeds.2020.07.032

Arnold K, Xu Y, Sparkenbaugh EM, Li M, Han X, Zhang X, et al. Design of anti-inflammatory heparan sulfate to protect against acetaminophen-induced acute liver failure. Sci Transl Med. 2020;12(535):eaav8075. https://doi.org/10.1126/scitranslmed.aav8075 PMid:32188725 DOI: https://doi.org/10.1126/scitranslmed.aav8075

Poterucha TJ, Libby P, Goldhaber SZ. More than an anticoagulant: Do heparins have direct anti-inflammatory effects? Thromb Haemost. 2017;117(3):437-44. https://doi.org/10.1160/TH16-08-0620 PMid:27975101 DOI: https://doi.org/10.1160/TH16-08-0620

Menon MN, Srivaths LV. Thromboembolism in children with multisystem inflammatory syndrome: A literature review. Pediatr Res. 2022;14:1–5. https://doi.org/10.1038/s41390-021-01873-0 DOI: https://doi.org/10.1038/s41390-021-01873-0

Tichelaar YI, Kluin-Nelemans HJ, Meijer K. Infections and inflammatory diseases as risk factors for venous thrombosis. A systematic review. Thromb Haemost. 2012;107(5):827-37. https://doi.org/10.1160/TH11-09-0611 PMid:22437808 DOI: https://doi.org/10.1160/TH11-09-0611

Wakefield TW, Greenfield LJ, Rolfe MW, DeLucia A 3rd, Strieter RM, Abrams GD, et al. Inflammatory and procoagulant mediator interactions in an experimental baboon model of venous thrombosis. Thromb Haemost. 1993;69(2):164-72. PMid:8456429 DOI: https://doi.org/10.1055/s-0038-1651574

Thourani VH, Brar SS, Kennedy TP, Thornton LR, Watts JA, Ronson RS, et al. Nonanticoagulant heparin inhibits NF-ΚB activation and attenuates myocardial reperfusion injury. Am J Physiol Heart Circ Physiol. 2000;278(6):H2084-93. https://doi.org/10.1152/ajpheart.2000.278.6.H2084 PMid:10843908 DOI: https://doi.org/10.1152/ajpheart.2000.278.6.H2084

Hochart H, Jenkins PV, Smith OP, White B. Low-molecular weight and unfractionated heparins induce a downregulation of inflammation: Decreased levels of proinflammatory cytokines and nuclear factor-KappaB in LPS-stimulated human monocytes. Br J Haematol. 2006;133(1):62-7. https://doi.org/10.1111/j.1365-2141.2006.05959.x PMid:16512830 DOI: https://doi.org/10.1111/j.1365-2141.2006.05959.x

Salas A, Sans M, Soriano A, Reverter JC, Anderson DC, Piqué JM, et al. Heparin attenuates TNF-alpha induced inflammatory response through a CD11b dependent mechanism. Gut. 2000;47(1):88-96. https://doi.org/10.1136/gut.47.1.88 PMid:10861269 DOI: https://doi.org/10.1136/gut.47.1.88

Rao NV, Argyle B, Xu X, Reynolds PR, Walenga JM, Prechel M, et al. Low anticoagulant heparin targets multiple sites of inflammation, suppresses heparin-induced thrombocytopenia, and inhibits interaction of RAGE with its ligands. Am J Physiol Cell Physiol. 2010;299(1):C97-110. https://doi.org/10.1152/ajpcell.00009.2010 PMid:20375277 DOI: https://doi.org/10.1152/ajpcell.00009.2010

Gonzales JN, Kim KM, Zemskova MA, Rafikov R, Heeke B, Varn MN, et al. Low anticoagulant heparin blocks thrombininduced endothelial permeability in a PAR-dependent manner. Vascul Pharmacol. 2014;62(2):63-71. https://doi.org/10.1016/j.vph.2014.01.005 PMid:24469066 DOI: https://doi.org/10.1016/j.vph.2014.01.005